Why is the international development community absent from debates on drug policy reform?
In a blog published today, Dr Schultze-Kraft, who is Governance Team Leader at IDS and co-chair of the Global Drug and Development Policy Roundup, calls for the formation of an international global drug and development policy network championed by a core group of development and drug policy organisations with policy capacity, convening power and an interest in making a bold contribution to moving the debate forward and identifying inroads for policy reform.
His recommendations follow two high profile events that were convened by IDS and funded by the Open Society Foundation, which examined how greater cooperation between the development and drugs policy communities could be fostered.
- See more at: http://www.ids.ac.uk/news/why-is-the-international-development-community-absent-from-debates-on-drug-policy-reform#sthash.ADumi3rR.dpuf
In a blog published today, Dr Schultze-Kraft, who is Governance Team Leader at IDS and co-chair of the Global Drug and Development Policy Roundup, calls for the formation of an international global drug and development policy network championed by a core group of development and drug policy organisations with policy capacity, convening power and an interest in making a bold contribution to moving the debate forward and identifying inroads for policy reform.
His recommendations follow two high profile events that were convened by IDS and funded by the Open Society Foundation, which examined how greater cooperation between the development and drugs policy communities could be fostered.
- See more at: http://www.ids.ac.uk/news/why-is-the-international-development-community-absent-from-debates-on-drug-policy-reform#sthash.ADumi3rR.dpuf
In a blog published today, Dr Schultze-Kraft, who is Governance Team Leader at IDS and co-chair of the Global Drug and Development Policy Roundup, calls for the formation of an international global drug and development policy network championed by a core group of development and drug policy organisations with policy capacity, convening power and an interest in making a bold contribution to moving the debate forward and identifying inroads for policy reform.
His recommendations follow two high profile events that were convened by IDS and funded by the Open Society Foundation, which examined how greater cooperation between the development and drugs policy communities could be fostered.
- See more at: http://www.ids.ac.uk/news/why-is-the-international-development-community-absent-from-debates-on-drug-policy-reform#sthash.ADumi3rR.dpuf
In a blog published today, Dr Schultze-Kraft, who is Governance Team Leader at IDS and co-chair of the Global Drug and Development Policy Roundup, calls for the formation of an international global drug and development policy network championed by a core group of development and drug policy organisations with policy capacity, convening power and an interest in making a bold contribution to moving the debate forward and identifying inroads for policy reform.
His recommendations follow two high profile events that were convened by IDS and funded by the Open Society Foundation, which examined how greater cooperation between the development and drugs policy communities could be fostered.
In a blog published today, Dr Schultze-Kraft, who is Governance Team Leader at IDS and co-chair of the Global Drug and Development Policy Roundup, calls for the formation of an international global drug and development policy network championed by a core group of development and drug policy organisations with policy capacity, convening power and an interest in making a bold contribution to moving the debate forward and identifying inroads for policy reform.
His recommendations follow two high profile events that were convened by IDS and funded by the Open Society Foundation, which examined how greater cooperation between the development and drugs policy communities could be fostered.
- See more at: http://www.ids.ac.uk/news/why-is-the-international-development-community-absent-from-debates-on-drug-policy-reform#sthash.ADumi3rR.dpuf
Click here to read the full article.
Keep up-to-date with drug policy developments by subscribing to the IDPC Monthly Alert.